Veterinary Use

Estimates indicate that 30%-50% of dogs and cats will be affected by osteoarthritis (OA) as they age, and that up to 60% of lameness in horses is related to OA. Animals with arthritis become tired more easily, and some longitudinal studies have reported that the condition can reduce animal lifespan.
Similar to its relief for human OA, MM-II offers promise as a durable, effective, and safe treatment for veterinary OA.

Moebius is developing MM-II for canine and feline osteoarthritis